P1: RLJ/OZN P2: PSB
0521779407-D-02 CUNY1086/Karliner 0 521 77940 7 June 4, 2007 21:9
514 Dysphagia Dyspnea
Stricture
■benign: endoscopic dilation, proton pump inhibitor for peptic stric-
ture
■malignant: surgery for early staging, endoscopic stent placement,
laser
Spasm
■nitrates, calcium-channel blocker
Achalasia
■pneumatic dilation, botulinum toxin injections (short acting),
myotomy surgery
follow-up
■Periodic visits for symptom survey to determine effectiveness of ther-
apy and need for additional treatment strategies
complications and prognosis
Prognosis
■good if diagnosis confirmed and therapy effective
Complications
■aspiration pneumonia
■weight loss
Dyspnea...........................................
THOMAS J. NUCKTON, MD
history & physical
■Dyspnea: subjective difficulty or distress in breathing
■Orthopnea: dyspnea when supine; characteristic of CHF; may occur
with asthma, other obstructive lung diseases, diaphragmatic paral-
ysis
■Trepopnea: dyspnea only in the lateral decubitus position; seen with
heart disease, unilateral pulmonary or pleural disease, unilateral
pleural effusion
■Platypnea: dyspnea only when upright; seen in pulmonary disease
that affects lung bases, also congenital heart disease with right-to-
left shunting on standing
■Paroxysmal nocturnal dyspnea: attacks of dyspnea at night; “cardiac
asthma” with CHF and valvular heart disease; patients with pul-
monary disease may also experience sudden onset dyspnea at night